Top Markets
#1 Pleasing Gold Pleasing Gold +1,540.29%
#2 PulseChain PulseChain +58.48%
#3 Merlin's Seal BTC Merlin's Seal BTC +32.82%
#4 BOOK OF MEME BOOK OF MEME +30.65%
#5 Ontology Gas Ontology Gas +23.61%
#6 Pump.fun Pump.fun +22.86%
#7 Unit Pump Unit Pump +22.86%
#8 Nockchain Nockchain +22.69%
#9 Neiro Neiro +20.67%
#10 RSK Infrastructure Framework RSK Infrastructure Framework +19.77%
Coin of the day
Pleasing Gold Pleasing Gold
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
PRISM BioLab Co.,LTD PRISM BioLab Co.,LTD

PRISM BioLab Co.,LTD

206A
Classificação em ações #26422
PRISM Pharma Co., Ltd. is a pharmaceutical enterprise dedicated to identifying... PRISM Pharma Co., Ltd. is a pharmaceutical enterprise dedicated to identifying and advancing small molecule compounds. Its core mission involves modulating protein-protein interactions. The company leverages a proprietary protein secondary structure mimetic library to regulate interactions between proteins within cells. A key product in its development pipeline is PRI-724, an anti-cancer CP/Catenin inhibitor. This drug targets both mature cancer cells and cancer stem cells, inducing them to transition from uncontrolled proliferation to differentiation. Hiroyuki Kouji founded the organization on November 2, 2006, and it is headquartered in Fujisawa, Japan.
Preço da ação
$1.10
Valor de mercado
$40.76M
Variação (1 dia)
3.68%
Variação (1 ano)
-13.12%
País
JP
Negociar PRISM BioLab Co.,LTD (206A)

Categoria

Healthcare
Lucros da PRISM BioLab Co.,LTD (206A)
Lucros em 2026 TTM: 0
De acordo com os últimos relatórios financeiros da PRISM BioLab Co.,LTD, os ganhos atuais da empresa são de 0. Em 2026, a empresa teve ganhos de 0, igual a aos ganhos de 2026, que foram de 0. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da PRISM BioLab Co.,LTD de 2026 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
Não há dados suficientes para as datas fornecidas.
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH